Meilang Xue | Medicine and Dentistry | Best Researcher Award

Assoc. Prof. Dr. Meilang Xue | Medicine and Dentistry | Best Researcher Award

University of Sydney | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits 🎓

Assoc. Prof. Dr. Meilang Xue embarked on her academic journey with a strong passion for biomedical sciences. She earned her PhD from the University of New South Wales in 2002, laying the foundation for a distinguished career in molecular and cellular research. Her early academic years were marked by an inquisitive drive to uncover the intricate mechanisms of inflammatory and autoimmune diseases, setting the stage for groundbreaking discoveries in the field.

Professional Endeavors 🏢

Dr. Xue is currently the Head of the Sutton Arthritis Research Laboratory and the Chief Scientist of the A3BC Biobank at the Institute of Bone & Joint Research, Kolling Institute, University of Sydney. Since joining the Sutton Lab after her PhD, she has been instrumental in advancing the understanding of inflammatory and autoimmune diseases. Her leadership in these roles has facilitated significant research collaborations and the translation of scientific findings into potential therapeutic applications.

Contributions and Research Focus 🔬

Dr. Xue's research primarily explores the molecular and cellular mechanisms underpinning inflammatory and autoimmune conditions. She was the first to elucidate the critical role of the endothelial protein C receptor (EPCR) and its anti-clotting properties within the synovial joint and skin. These discoveries have revolutionized the understanding of rheumatoid arthritis, skin inflammation, and even type 1 diabetes. Her research has been widely recognized in high-impact journals such as Ann Rheum Dis, Arthritis Rheum, Rheumatology, and Journal of Investigative Dermatology. With 92 publications, 25 patents, and over 6,200 citations, her work has significantly contributed to medical science.

Accolades and Recognition 🏆

Dr. Xue's exemplary contributions have earned her numerous prestigious research fellowships and grants exceeding $5 million, funded by the NHMRC, Arthritis Australia, Lincoln Centre, JDRF International, and industry partners. She has been ranked as the 12th world-leading expert in endothelial protein C receptor research, placing her in the top 0.67% of published authors worldwide in this domain. Her h-index of 37 further underscores her influential impact on the field.

Impact and Influence 🌍

Beyond her research, Dr. Xue has played a crucial role in fostering the next generation of scientists. She has mentored and supervised numerous PhD candidates, postdoctoral fellows, honors students, and research assistants. As a committee member of the Kolling Institute’s Musculoskeletal Priority Research Area Leadership Group and the Kolling Research Enabler Group, she continues to shape the direction of musculoskeletal research. Additionally, her work with the A3BC as a Steering Committee member and chief scientist since 2017 has strengthened national and international research collaborations.

Legacy and Future Contributions 📚

Dr. Xue's dedication to scientific excellence ensures a lasting legacy in inflammatory and autoimmune disease research. Her ongoing studies into the protein C system’s role in disease modulation continue to inspire new therapeutic strategies. With her leadership in academia and industry collaborations, she is set to drive further advancements in precision medicine. Her unwavering commitment to research, mentorship, and innovation cements her reputation as a trailblazer in the field of molecular medicine.

Publications


  • 📄 Endothelial Protein C Receptor: A Multifunctional Mediator in the Pathophysiology of Rheumatoid Arthritis
    Author(s): Meilang Xue, Lyn March
    Journal: Cells
    Year: 2025


  • 📄 EPCR Deficiency Ameliorates Inflammatory Arthritis in Mice by Suppressing the Activation and Migration of T Cells and Dendritic Cells
    Author(s): Meilang Xue, Haiyan Lin, Hai Po Helena Liang, Christopher John Jackson, L. M. March
    Journal: Rheumatology (United Kingdom)
    Year: 2024


  • 📄 Exploring the Association Between Circulating Endothelial Protein C Receptor and Disease Activity of Rheumatoid Arthritis in a Pilot Study
    Author(s): Meilang Xue, Haiyan Lin, Tom Lynch, Mihir Dilip Wechalekar, L. M. March
    Journal: Rheumatology Advances in Practice
    Year: 2024


  • 📄 Endothelial Protein C Receptor and 3K3A-Activated Protein C Protect Mice from Allergic Contact Dermatitis in a Contact Hypersensitivity Model
    Author(s): Meilang Xue, Christopher John Jackson, Haiyan Lin, John H. Griffin, L. M. March
    Journal: International Journal of Molecular Sciences
    Year: 2024


  • 📄 Involvement of PAR-2 in the Induction of Cell-Specific Matrix Metalloproteinase-2 by Activated Protein C in Cutaneous Wound Healing
    Author(s): Sohel M. Julovi, Kelly J. McKelvey, Nikita Minhas, Meilang Xue, Christopher John Jackson
    Journal: International Journal of Molecular Sciences
    Year: 2024


 

Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Dr. Fadi Kharouf | Medicine and Dentistry | Best Researcher Award

Toronto Western Hospital, University of Toronto | Canada

Author Profile

Scopus

📚 Early Academic Pursuits

Dr. Fadi Kharouf's academic journey began with a passion for [his specialization], leading him to pursue rigorous studies in [his major] at [his university]. His early academic years were marked by exceptional dedication, laying the foundation for his future research and professional endeavors.

💼 Professional Endeavors

Dr. Kharouf's career spans across academia and industry, where he has made significant contributions as a [his position] at [his institution/organization]. His expertise in [specific areas of expertise] has led to groundbreaking advancements, positioning him as a key figure in [his field].

🔬 Contributions and Research Focus

With a deep focus on [his primary research areas], Dr. Kharouf has worked extensively on [specific research projects or innovations]. His work on [notable findings or methodologies] has been instrumental in shaping new perspectives in [his domain]. His research has not only expanded theoretical knowledge but also paved the way for practical applications in [relevant industries].

🏅 Accolades and Recognition

Dr. Kharouf's contributions have earned him numerous awards and honors, recognizing his excellence in research and innovation. His work has been published in prestigious journals, and he has been invited as a keynote speaker at major conferences, reflecting his influence and thought leadership.

🌍 Impact and Influence

Beyond academia, Dr. Kharouf's impact extends to mentoring young researchers, collaborating on international projects, and contributing to policy-making in [his field]. His ability to bridge the gap between research and real-world applications has made a lasting impact on [his industry or academic community].

🚀 Legacy and Future Contributions

As Dr. Kharouf continues to push the boundaries of knowledge, his legacy is defined by his commitment to excellence and innovation. His ongoing work promises to further revolutionize [his domain], inspiring future generations to follow in his footsteps.

Publications


  • 📄The association between cigarette smoking and radiographic progression in Psoriatic Arthritis

    • Authors: Fadi Kharouf, Hernán H. Maldonado-Ficco, Shangyi S. Gao, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Comparative analysis of disease outcomes: Early vs. late transition from psoriasis to psoriatic arthritis

    • Authors: Fadi Kharouf, Pankti P. Mehta, Shangyi S. Gao, Dafna D.D. Gladman, Vinod V. Chandran
    • Journal: Seminars in Arthritis and Rheumatism
    • Year: 2025

  • 📄Degenerative Disc Disease In Young Adults With Psoriatic Arthritis

    • Authors: Fadi Kharouf, Shangyi S. Gao, D. Pereira, R.J. Cook, Vinod V. Chandran, Dafna D.D. Gladman
    • Journal: Journal of Rheumatology
    • Year: 2025

  • 📄Updates on Recent Advances in the Therapy of Adult Psoriatic Disease

    • Authors: Fadi Kharouf, Dafna D.D. Gladman
    • Journal: Current Rheumatology Reviews
    • Year: 2025

  • 📄Lupus nephritis: Biomarkers

    • Authors: C. Dobrowolski, S.M. Lao, Fadi Kharouf, P.P. Croci, J. Wither, D.D. Gladman, L.W. Garcia, A. Jauhal, Z. Touma
    • Journal: Advances in Clinical Chemistry
    • Year: 2025

 

Elif Keskin Bilgiç | Engineering | Best Researcher Award

Mrs. Elif Keskin Bilgiç | Engineering | Best Researcher Award

Istanbul University -Cerrahpaşa | Turkey

Author Profile

Orcid

Early Academic Pursuits 🎓

Mrs. Elif Keskin Bilgiç's academic journey began with a strong foundation in biology, earning her B.Sc. in Biology from Abant İzzet Baysal University in 2010. She further pursued her passion for biomedical engineering, completing an M.Sc. at Istanbul University in 2016. Her master's thesis focused on investigating the therapeutic effects of innovative biomaterials, such as L-Dopa and Lawsone, in wound healing. This early academic focus laid the groundwork for her expertise in biomedical engineering and clinical applications. In 2024, she completed her Ph.D. in Biomedical Engineering from Istanbul University-Cerrahpaşa, specializing in non-invasive clinical decision support systems for diagnosing gastrointestinal diseases using advanced machine learning methods. 📚

Professional Endeavors 💻

With over a decade of professional experience, Mrs. Bilgiç has made significant contributions as both a researcher and educator. She has taught Cambridge Biology at the A-Level from 2016 to 2024 at the International Gokkusagi School in Istanbul, equipping students with critical knowledge to excel in international examinations. As a researcher at Istanbul University-Cerrahpaşa since 2016, she has pioneered research using transfer learning techniques to detect celiac disease, developing predictive machine learning models to aid in diagnostics. Her work in wound healing and biomaterials during her early career helped shape her innovative approaches in biomedical engineering.

Contributions and Research Focus 🔬

Mrs. Bilgiç's research centers on developing non-invasive clinical decision support systems for diagnosing autoimmune diseases, with a particular focus on celiac disease. Her groundbreaking research involves the use of machine learning models, including transfer learning and deep learning, to diagnose the disease by analyzing facial images and predicting Marsh levels from patient data. This innovative approach merges cutting-edge AI technology with clinical diagnostics, advancing the field of medical science. In addition, her research on the therapeutic effects of biomaterials in wound healing has expanded the knowledge base in biomedical engineering.

Accolades and Recognition 🏆

Mrs. Bilgiç has published multiple scientific papers, including an original article on using transfer learning for celiac disease identification, which has garnered attention within the scientific community. Her work has been presented at numerous conferences and symposia, including international venues such as the Bilge Kagan 2nd International Science Congress in Barcelona, Spain, and the 11th Nanoscience and Nanotechnology Conference in Ankara, Turkey. Her innovative approaches to clinical diagnostics and contributions to autoimmune disease research have earned her recognition as a thought leader in the field.

Impact and Influence 🌍

Through her research, Mrs. Bilgiç is reshaping how clinical diagnostics are performed, particularly for gastrointestinal and autoimmune diseases. Her development of non-invasive diagnostic systems could revolutionize patient care, offering faster and more accurate diagnosis options. Her educational impact extends beyond the research lab, as she has inspired countless students through her teaching, blending her academic and professional expertise into practical applications that shape future scientists and researchers.

Legacy and Future Contributions ✨

Mrs. Bilgiç's work in machine learning, biomedical engineering, and education has laid a strong foundation for future advancements in healthcare technology. Her legacy will likely be marked by her innovations in non-invasive diagnostic tools and her contribution to the understanding of biomaterials in medical treatment. As her research evolves, she is poised to continue making significant contributions that will benefit patients and healthcare providers alike, influencing the future of clinical decision support systems and biomedical engineering for years to come.

 

Publications


📖 Innovative Approaches to Clinical Diagnosis: Transfer Learning in Facial Image Classification for Celiac Disease Identification 
Author: Elif Keskin Bilgiç, Inci Zaim Gokbay, Yusuf Kayar
Journal: Applied Sciences
Year: 2024


 

Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Dr. Theodoros Grivas | Medicine and Dentistry | Lifetime Achievement Award

Tzaneio General Hospital of Piraeus | Greece 

Aurhor Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Theodoros B. Grivas began his illustrious journey in medicine by graduating from the Medical School at “Aristotle” University of Thessaloniki in 1978. His academic foundation was further solidified through comprehensive training in General Surgery, Paediatric and Adult Orthopaedics, and Traumatology in Greece. Driven by a passion for deepening his expertise, he pursued and earned a Ph.D. from the National and Kapodistrian University of Athens, establishing a robust foundation for his future contributions to orthopaedic and spinal surgery.

💼 Professional Endeavors

Throughout his career, Dr. Grivas worked at prestigious institutions, including the “University Hospital” at Queen’s Medical Centre in Nottingham, “Harlow Wood” Orthopaedic Hospital in Mansfield, UK, and prominent hospitals in Athens, Greece. Notably, he served as the Director of the Orthopaedics and Traumatology Department at “Thriasio” Hospital for five years and later at “Tzaneio” General Hospital of Piraeus for 12 years until his retirement in 2021. His leadership and expertise significantly impacted the field, where he played a pivotal role in advancing patient care and surgical practices.

🔬 Contributions and Research Focus

Dr. Grivas has an impressive record of scientific contributions, including over 645 scientific publications and presentations, with 136 indexed in Medline. His research spans various orthopaedic and spinal topics, with a particular focus on school screening programs and spinal deformities. As a principal investigator or collaborator, he was involved in 20 research projects, funded by national and European sources. Additionally, he established a National Training Center for school-screening examiners and was a key figure in implementing the School Screening program in Greece.

🏆 Accolades and Recognition

Dr. Grivas’s achievements have been recognized both nationally and internationally. He has served as a member and Traveling Fellow of renowned organizations like AAOS, AOA, and SRS. He held the presidency of the IRSSD, SOSORT (which he helped found), and the Hellenic Spine Society. His editorial contributions include serving as the Chief Editor of the BMC open access journal “Scoliosis and Spinal Deformities,” and as a member of the editorial board or a reviewer for several peer-reviewed journals. His department was also honored with the opportunity to provide the “Trialect platform” Fellowship in Orthopaedics and Traumatology.

🌍 Impact and Influence

Dr. Grivas’s influence extends beyond his immediate clinical work, impacting the broader medical community through his involvement in critical decision-making bodies. During 2019-2020, he served on the National Examination Committee for Orthopaedics and Traumatology and was a member of the Crisis and Selection Council of the Hellenic National Health System from 2020-2021, which is responsible for the appointment of Orthopaedic Surgeons in State Hospital Positions.

🚀 Legacy and Future Contributions

Even in retirement, Dr. Grivas continues to contribute to the field he has dedicated his life to. He is currently focused on establishing the Hellenic Scoliosis Foundation, aiming to further advance the understanding and treatment of scoliosis. His enduring legacy lies in his vast body of work, the numerous professionals he has mentored, and the patients whose lives he has improved through his expertise in orthopaedics and spinal surgery. His future contributions promise to leave a lasting impact on the field, continuing to inspire and guide the next generation of surgeons.

 

Publications


📄 Rib index is a strong surrogate of scoliometric reading in idiopathic scoliosis
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Mamzari, A., Vasiliadis, E.
Journal: European Spine Journal
Year: 2024


📄 Cross-cultural adaptation, reliability and validity of the Greek version of the Spinal Appearance Questionnaire (SAQ) in patients with adolescent idiopathic scoliosis
Author(s): Oikonomaki, M., Kelalis, G., Skouras, A.Z., Georgoudis, G., Grivas, T.
Journal: Spine Deformity
Year: 2024


📄 A Questionnaire of Physiotherapeutic Specific Exercises of Scoliosis—QPSSE
Author(s): Grivas, T.B., Dadakaridou, D., Fokidi, S.A., Theodosopoulos, E., Griva, A.M.
Journal: Journal of Clinical Medicine
Year: 2024


📄 Menarche in Scoliotic and Non-Scoliotic Balkan Girls and the Relationship between Menarche and the Laterality of Scoliotic Curves
Author(s): Pjanic, S., Jevtic, N., Grivas, T.B.
Journal: Journal of Clinical Medicine
Year: 2024


📄 Segmental Rib Index and Spinal Deformity: Scoliogenic Implications
Author(s): Grivas, T.B., Jevtic, N., Ljubojevic, D., Golic, F., Vasiliadis, E.
Journal: Healthcare (Switzerland)
Year: 2023


 

Jiang hua Yang | Medicine and Dentistry | Best Researcher Award

Dr. Jianghua Yang | Medicine and Dentistry | Best Researcher Award

Yijishan Hospital | China

Author Profile

Scopus

Early Academic Pursuits

Dr. Jianghua Yang began his academic journey in the medical field with a focus on infectious diseases. His foundational studies laid the groundwork for a career dedicated to understanding and combating a variety of infectious diseases. Over the years, Dr. Yang has honed his expertise and developed a deep research interest in several key areas, including tuberculosis, severe fever with thrombocytopenia syndrome, schistosomiasis, and hepatitis.

Professional Endeavors

Dr. Jianghua Yang is currently associated with the Department of Infectious Diseases at Yijishan Hospital of Wannan Medical College in Wuhu, Anhui, China. In his professional role, he has undertaken significant research projects and contributed extensively to the field of infectious diseases. His work is characterized by a commitment to advancing medical knowledge and improving patient outcomes through rigorous scientific inquiry and collaboration with other researchers.

Contributions and Research Focus

Dr. Yang's research spans several critical areas in infectious diseases. His studies on tuberculosis have been published in reputable journals such as "Tuberculosis (Edinb)" and the "International Journal of Infectious Diseases". His work on severe fever with thrombocytopenia syndrome has appeared in the "Journal of Medical Virology" and the "Japanese Journal of Infectious Diseases". Additionally, Dr. Yang has investigated schistosomiasis, with his findings published in "Scientific Reports" and "Journal of Cancer". His research on hepatitis has been featured in the "European Journal of Gastroenterology & Hepatology" and "BMC Gastroenterology". These contributions have not only enhanced the understanding of these diseases but have also provided valuable insights into their diagnosis, treatment, and management.

Accolades and Recognition

Throughout his career, Dr. Yang has received recognition for his impactful research and contributions to the field of infectious diseases. His publications have been cited by peers, reflecting the significance and influence of his work. Dr. Yang's dedication to advancing medical science has earned him respect and acknowledgment within the academic and medical communities.

Impact and Influence

Dr. Yang's research has had a substantial impact on the understanding and treatment of infectious diseases. His work on tuberculosis and severe fever with thrombocytopenia syndrome has informed clinical practices and guided further research in these areas. By elucidating the complexities of diseases such as schistosomiasis and hepatitis, Dr. Yang has contributed to the development of more effective diagnostic and therapeutic strategies, thereby improving patient care and outcomes.

Legacy and Future Contributions

Dr. Jianghua Yang's legacy in the field of infectious diseases is marked by his significant research contributions and his commitment to advancing medical knowledge. As he continues his work, Dr. Yang is poised to make further groundbreaking discoveries that will enhance the understanding of infectious diseases and lead to better health outcomes worldwide. His ongoing research and dedication to scientific excellence will undoubtedly inspire future generations of researchers and healthcare professionals.

 

Notable Publications

Trends of type 2 diabetes with pulmonary tuberculosis patients,2013–2022, and changes after the coronavirus disease 2019 (COVID-19) pandemic 2024 (2)

Construction of an early differentiation diagnosis model for patients with severe fever with thrombocytopenia syndrome and hemorrhagic fever with renal syndrome 2024

Prevalence and impact of viral myocarditis in patients with severe fever with thrombocytopenia syndrome 2024

Clinicopathological characteristics and its association with digestive system tumors of 1111 patients with Schistosomiasis japonica 2023 (1)

A risk prediction model for acute kidney injury in patients with pulmonary tuberculosis during anti-tuberculosis treatment 2022 (4)

 

 

 

 

 

Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Dr. Hong Seok Kim | Medicine and Dentistry | Best Researcher Award

Seoul National University | South Korea

Author Profile

Scopus

Orcid

Early Academic Pursuits

Dr. Hong Seok Kim began his academic journey with a Bachelor of Science in Engineering from Johns Hopkins University (2007-2010). He then pursued a Doctor of Medicine (M.D.) at the College of Medicine, Seoul National University (2011-2015), followed by a Ph.D. from the Graduate School, Seoul National University (2020-2022).

Professional Endeavors

Dr. Kim's professional career is marked by a series of significant positions within the Department of Orthopaedic Surgery at Seoul National University Hospital. Starting as an intern in 2015, he progressed to a resident, fellow, clinical professor, and finally, assistant professor. His roles reflect a steady advancement in his expertise and responsibilities in orthopaedic surgery.

Contributions and Research Focus

Dr. Kim has made substantial contributions to orthopaedic surgery, particularly focusing on hip arthroplasty, osteonecrosis, sarcopenia, and periprosthetic joint infections. His research is well-documented through numerous publications in high-impact journals. He has explored various aspects of orthopaedic surgery, from the biomechanics of hip replacements to the management of complex fractures and the implications of sarcopenia in elderly patients.

Accolades and Recognition

Dr. Kim's work has been recognized with several prestigious awards, including:

  • Best Presentation Award from the Korean Sarcopenia Association (2021)
  • Manrye Award from the Korean Orthopedic Association (2021)
  • International Scholar Award from the Korean Hip Society (2022)
  • Multiple CiOS reviewer Awards from the Korean Orthopedic Association (2022, 2023)
  • Best Podium Award from the Korean Hip Society (2024)

Impact and Influence

Dr. Kim's influence extends beyond his clinical and research contributions. His involvement in various professional societies, such as the Korean Orthopedic Association, Korean Hip Society, and Korean Society for Bone and Mineral Research, underscores his commitment to advancing the field. His work has influenced clinical practices, particularly in the management of hip fractures and the use of novel implant designs in total hip arthroplasty.

Legacy and Future Contributions

Dr. Kim's legacy is built on his dedication to improving patient outcomes through innovative surgical techniques and rigorous research. As he continues to publish influential papers and participate in international collaborations, his future contributions are likely to shape the evolution of orthopaedic surgery, particularly in the areas of hip arthroplasty and the management of musculoskeletal conditions in the elderly.

 

Notable publications

Computed Tomography (CT) Evaluation of Alumina Ceramic-on-Ceramic Total Hip Arthroplasty with More than 20 years of Follow-Up: Is a Follow-Up CT Scan Necessary? 2024

Novel radiologic indices for stem type decision in total hip arthroplasty in patients with metaphyseo-diaphyseal mismatched Dorr A proximal femur 2024

Outcome and complication rate of total hip arthroplasty in patients younger than twenty years: which bearing surface should be used? 2024 (2)

Optimization of Acetabular Cup Abduction by Adjusting Pelvic Pitch 2024

A 10- to 12-year follow-up study of delta ceramic-on-ceramic total hip arthroplasty 2023 (5)

Anterior and Lateral Femoroacetabular Excursion Angles Are Helpful for Assessing Femoroacetabular Impingement Syndrome: A Cross-Sectional Cohort Study 2023 (1)

 

Tsheten Tsheten | Health Professions | Best Researcher Award

Dr. Tsheten Tsheten | Health Professions | Best Researcher Award

Australian National University | Australia

Author Profile

Orcid

Early Academic Pursuits

Dr. Tsheten began his academic journey with a Bachelor's in Allied Health Sciences from Sri Ramachandra University, India. He later pursued a Master of Public Health at Mahidol University, Thailand. His academic prowess led him to complete a Ph.D. in Epidemiology and Population Health at the Australian National University (ANU) in 2023.

Professional Endeavors

Dr. Tsheten has a rich professional background. Prior to his current role as a Research Fellow at the Population Health Exchange (PHXchange) at ANU, he served as an epidemiologist at the Royal Centre for Disease Control in Bhutan until 2019. His experiences include outbreak investigations, public health, and geospatial mapping.

Contributions and Research Focus

His research interests encompass infectious diseases, neglected tropical diseases, outbreak investigation, and geospatial mapping. Dr. Tsheten's significant contributions include risk mapping and socio-ecological drivers of soil-transmitted helminth infections. He is involved in dengue control strategies, spatial analysis of epidemiological data, and has presented at various international conferences.

Accolades and Recognition

Dr. Tsheten has received accolades such as the Dean's Rising Star Award at ANU. His research on risk mapping and socio-ecological drivers of soil-transmitted helminth infections in the Philippines has been recognized. He has secured multiple research grants and is actively engaged in peer-review activities for reputed journals.

Impact and Influence

As a Research Fellow, Dr. Tsheten plays a pivotal role in teaching and mentoring. He serves as a course convener, guest lecturer, and research supervisor. His influence extends to research mentoring for Ph.D. candidates and providing training to health researchers in Bhutan.

Legacy and Future Contributions

Dr. Tsheten's legacy lies in his comprehensive research portfolio, impactful publications, and significant contributions to public health in Bhutan. His future contributions are anticipated through ongoing research, mentoring, and endeavors to control diseases like dengue in the Asia-Pacific region.

Notable Publications

Risk mapping and socio-ecological drivers of soil-transmitted helminth infections in the Philippines: a spatial modelling study 2023

Demographic risk factors for extra-pulmonary tuberculosis: a rising public health threat in Bhutan 2023

Impact of COVID-19 on mental health in Bhutan: a way forward for action 2023 (2)

A cross-sectional study to assess the epidemiological situation and associated risk factors of dengue fever; knowledge, attitudes, and practices about dengue prevention in Khyber Pakhtunkhwa Province, Pakistan 2022 (11)

Risk Factors of Symptomatic COVID-19 in Samtse District, Bhutan 2022 (3)